Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome

Francesco Ciccia(University of Campania "Luigi Vanvitelli"), G Triolo(Department of Health)

Lara D. Veeken

March 6, 2014

10.1093/rheumatology/keu004

Cited by 51

Related Papers

Interleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis

|Arthritis & Rheumatism|2011|128

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting

|Arthritis & Rheumatology|2020|113

Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity

|Lara D. Veeken|2014|15